Abstract Outcome measurement in clinical genetics is challenging. Robust outcome measures are needed to provide evidence to support service development within genetic counseling. The Genetic Counselling Outcome Scale (GCOS-24), a Patient Reported Outcome Measure (PROM), was developed in English and validated with clinical genetics patients in the British NHS. This study reports the translation and adaptation of the GCOS-24 for use in Denmark. GCOS-24 was translated and back translated, supervised by an expert committee. Feedback on the first version was collected from genetic counseling patients in qualitative interviews focusing on instructions for use, response options and specific items considered semantically difficult. After further adjustment the adapted and translated version was administered to a second sample of patients, with responses analyzed using descriptive statistics. Eighteen interviews were conducted, and led to adjustment of item wording. Sixty-one patients completed the final version GCOS-24dk. Internal consistency is good (Cronbach's α =0.79), with an acceptable number of missing responses and no floor or ceiling effect observed. GCOS-24 has been successfully translated and adapted for use in a Danish setting. The study confirms the feasibility of local adaptation of patient reported outcome measures and stresses the importance of adaptation, even across quite similar populations and health care systems.
Introduction
Evaluation of clinical genetics services (CGS) has been a difficult challenge for service providers and for researchers. Although patients' health outcomes may be improved after attendance at clinical genetics, for example for cancer genetics and cardiac genetics patients who may be offered screening and health interventions to reduce risk, these health status outcomes are rarely directly attributed, in the short-term, to clinical genetics. Patient-reported outcome measures (PROMs) are gaining prominence in healthcare evaluation across the world. PROMs are short, self-completion questionnaires completed by patients before and after use of a healthcare service, that are designed to measure constructs that are valued by patients as healthcare outcomes. In England, some healthcare services provided by the NHS such as elective surgery for hip and knee replacement are now routinely evaluated using PROMs, and this may be extended to all NHS services (Judge et al. 2012; Nuttall et al. 2013; Neuburger et al. 2013) . PROMs are also of increasing importance in US healthcare, with developments managed through the PROMIS initiative (Reeve et al. 2007; Cella et al. 2007 Cella et al. , 2010 Forrest et al. 2012) . With possible future funding of healthcare, Electronic supplementary material The online version of this article (doi:10.1007/s10897-017-0086-7) contains supplementary material, which is available to authorized users.
including clinical genetics services, potentially at least partially dependent upon performance against PROMs, evaluation using PROMs requires availability of reliable and responsive measurement tools. Appropriately validated PROMs are furthermore a prerequisite for research evaluating the effectiveness of genetic counseling and the continued development of evidence based practice in clinical genetics.
Health questionnaires commonly used as PROMs in other medical specialties, e.g. Euroqol or EQ-5D, which captures five domains: mobility, self-care, usual activities, pain/discomfort, anxiety/depression (Herdman et al. 2011) may not be useful in clinical genetics, since genetic counseling and testing interventions only rarely affect physical health status directly (McAllister et al. 2012a ). In oncogenetics, for example, the aim of the consultation is often to equip the patient to make decisions regarding cancer screening and risk-reducing surgery, rather than to recommend any particular risk management option. Likewise genetic testing and counseling for families with a disabled child are often undertaken to generate accurate recurrence risks and offer options for prenatal diagnosis and/or preimplantation genetic diagnosis. Uptake of cancer screening or prenatal diagnosis could be reported as patient outcomes, but uptake of these options would not capture any patient-reported outcomes of genetic counseling and testing interventions and could be considered unethical, particularly in the context of prenatal diagnosis, since the choice to have prenatal diagnosis is exquisitely preference-based. Measuring the accuracy of patient recall of risk figures provided in genetic counseling could partially measure the effectiveness of the educational components of genetic counseling. However, it is well known that patients employ heuristics or mental 'shortcuts' when processing information for decision-making, and may develop a composite 'sense' of risk that is quite different from the risk as understood by their health care provider despite effective risk communication (Austin 2010) . Measuring the accuracy of patient risk figure recall may only measure a limited part of what the patient may have gained from genetic counseling. Nevertheless, there is a need to evaluate whether genetic counseling and testing interventions do provide benefits to patients. It is also increasingly important that clinical genetics services can demonstrate these benefits to funders.
Although more than 60 different PROMs were reported in a 2008 systematic review of measures used to evaluate genetic counseling and testing interventions (Payne et al. 2008 ), many of these had undergone only very limited psychometric validation, with only five measures (Functional Assessment of Cancer Therapy-General (Cella et al. 1993; Brady et al. 1997 ); Spielberger State Trait Anxiety Inventory (STAI) (Spielberger et al. 1970; Marteau and Bekker 1992) ; Impact of Event Scale (IES) (Horowitz et al. 1979) ; Global Severity Index (GSI) of the Symptom Check List-90 (SCL90) (Derogatis et al. 1974; Derogatis 1983) ; General Health Questionnaire (GHQ) (Goldberg and Hillier 1979; Goldberg and Williams 1988) having been assessed for responsiveness, a key property of any measure to be used as a PROM (Kasparian et al. 2007; Payne et al. 2008; McAllister and Dearing 2014) .
Clinical genetics services in Denmark would benefit from having a PROM available. Denmark is a small country and only approximately 6 million people speak Danish. This will be important for Denmark to keep pace with genomic medicine in the future. The Genetic Counseling Outcome Scale (GCOS-24) and the English language version of the Hebrew Perceived Personal Control (PPC) questionnaire, are two wellvalidated English language PROMs specific to clinical genetics services (McAllister et al. 2011b (McAllister et al. , 2012b , that could be adapted for use in Denmark. Both GCOS-24 and PPC were developed through extensive and rigorously conducted validation in appropriate samples and both measures demonstrate good evidence of validity, internal consistency and responsiveness. GCOS-24 has demonstrated statistically significant correlations (n = 395) with internal health locus of control (r = 0.270), PPC (r = 0.554), satisfaction with life (r = 0.444) and authenticity (r = 0.206). Test-retest reliability (stability) of GCOS-24 (n = 64) is good (r = 0.86) and sensitivity to change over time has been demonstrated after genetic counselling/testing (n = 241) with a medium-to-large effect size (Cohen's d = 0.70). Internal consistency of GCOS-24 is high (Cronbach's α = 0.87) (n-241). The PPC has also been demonstrated to have high internal consistency (n = 395) (Cronbach's α = 0.83) and convergent validity (n = 395) with internal health locus of control (r = 0.350), satisfaction with life (r = 0.333) and authenticity (r = 0.150). PPC was also shown to be sensitive to change over time (n = 241), identifying moderate changes in PPC following clinic attendance (Cohen's d = 0.40). However, stability of the English language PPC has not yet been demonstrated. Furthermore, GCOS-24 was developed with the collaboration of a range of patient organizations representing many different genetic conditions, where PPC has not. The GCOS-24 was designed to capture the following five dimensions: & decisional control: ability to make important life decisions in an informed way & cognitive control: having sufficient information about the (genetic) condition, including risks to self and relatives, and any treatment, prevention and support & behavioral control: ability to make effective use of the health and social care systems for the benefit of the whole family & emotional regulation: ability to manage one's feelings about having a genetic condition in the family & hope: for a fulfilling family life for oneself, one's family, and/or one's future descendents.
This is similar to, but broader than the construct captured by the PPC questionnaire, which comprises decisional, cognitive and behavioral control only. There is evidence that GCOS-24 may capture patient benefits from clinical genetics services with a larger effect size than PPC (McAllister et al. 2011a (McAllister et al. , 2012b .
The Minimal Clinical Important Difference (MCID) of neither GCOS-24 nor of PPC has yet been established. The MCID is used to interpret patient scores on PROMs and is the smallest change that is important to patients as being meaningful and relevant (Jaeschke et al. 1989; Stratford et al. 1998; Copay et al. 2007; King 2011) . However, MCIDs are not yet available for any clinical geneticsspecific PROMs, as far as we are aware, although there is work ongoing to establish the MCID for GCOS-24. Because GCOS-24 was developed in close collaboration with patient groups, has demonstrated stability (which PPC does not) and because GCOS-24 demonstrated a larger effect size than PPC in the same sample of clinical genetics patients (McAllister et al. 2011b (McAllister et al. , 2012b , GCOS-24 was selected as the measure of choice for adaptation to the Danish context.
The present study reports on translation and initial crosscultural adaptation of GCOS-24 for use in Denmark. This study demonstrates the feasibility of translation and adaptation of GCOS-24 for use in a different language in a closely related, but different culture.
Materials and Method

Setting
In Denmark clinical genetic services are provided through six clinical genetics departments, each servicing a geographically defined region of Denmark. The work was done at the Kennedy Center Genetic Counseling Clinic, Rigshospitalet, Copenhagen University Hospital. Patients from the Copenhagen metropolitan area and the neighboring region, region Sjaelland, needing genetic counseling are seen at Copenhagen University Hospital Departments of clinical genetics. The Kennedy Center Genetic Counseling Clinic is a part of this department.
Patients are referred by family physicians and by physicians from other specialties for a wide range of potentially genetic indications. About half of the patients are referred due to a suspected hereditary cancer syndrome. Other common indications for referral include intellectual deficits in childhood and suspected hereditary eye conditions. The patient population is comparable to other sites providing genetic counseling in Denmark, with slightly more patients with hereditary eye disorders due to a local specialization. Approximately 500 new patients are referred per year to the site.
Expert Committee
The project team comprised the 'expert committee' recommended by Beaton et al. (2000) to oversee the translation-adaptation process. The team included four clinical geneticists (BRD, TDH, TBH, ST) working in the department with varying length of clinical genetics experience (1-15 years), an expert in qualitative research methods (GO) and an experienced, certified translator (GD). At each of the three committee meetings, a report of decisions and discussions was prepared and sent to one of the original developers of the GCOS-24 (co-author MM) who provided guidance on study design and advised on psychometric validation. The team met at the points in time recommended in published guidelines (Beaton et al. 2000) . Item wording was discussed at the meetings in Danish, a language not spoken by MM. Because of this, some meetings were held over two days, with time for MM to clarify points raised between the first and the second half of the meeting.
Approach and Translation Process
The approach to this work was adapted from guidelines for translation and cross-cultural adaptation of PROMs developed by Wild et al. (2005) (ISPOR guidelines) and Beaton et al. (2000) involving the following steps (Table 1) . Two independent translation groups were created. Translation group 1 conducted the translations from English into Danish, and Translation group 2 conducted the backtranslations from Danish into English. Translation group 1 comprised one 'context aware' (i.e. familiar with clinical genetics) translator with experience in medical genetics and fluent in English (co-author BD), and one 'context unaware' (i.e. naïve to clinical genetics) certified EnglishDanish translator. Translation group 2 comprised one 'context aware' psychologist with experience of psychometrics but not of clinical genetics and a 'context unaware' certified translator, both native English speakers who also speak Danish fluently. Translation group 1 created two independent Danish translations of GCOS-24, then met and agreed version A of the Danish language GCOS-24: GCOS-24dk. Version A was then back-translated independently by Translation group 2. Version A, both translations and both back-translation, along with the reports of issues encountered in the translation process were then reviewed by the expert committee to agree on wording and create Version B. For each translated item semantic, idiomatic, experiential and conceptual equivalence were discussed, with special attention to wording that back-translation indicated to be potentially problematic, and to items where translators had documented difficulties or ambiguities.
Test of GCOS-24dk Version B
The aim in this part of the study was to obtain the views of Danish people from families affected by (potentially) genetic conditions, or who have a family history that is of concern to them, about whether items in the GCOS-24dk are meaningful and easy to understand. To this end, we recruited patients referred to the Kennedy Center Genetic Counseling Clinic, Rigshospitalet, Copenhagen University Hospital, as these patients are useful informants. Consecutive patients who had been seen in Kennedy Center genetics clinics during the study period were screened for inclusion, and invited to participate in the study using appropriate informed consent procedures. In November 2012 the questionnaire and an invitation letter describing the study were distributed by mail to all eligible patients, who had received genetic counseling at the clinic in October 2012. Similarly, all eligible patients attending the clinic in November 2012 were handed an invitation letter and the GCOS-24dk version B in the waiting room prior to their appointment. Inclusion criteria were:
& aged above 18 years of age & have had an appointment for genetic counseling & speak Danish & have mental and physical capacity to participate Consenting patients were asked to return the questionnaire either at the beginning of the consultation (before receiving genetic counseling) or if they wanted more information regarding the purpose of the study to ask their clinician about this and then complete and return the questionnaire by mail after the consultation. Also, all consenting participants were asked to provide a telephone number if they were willing to participate in a short semi-structured telephone interview about the GCOS-24dk version B questionnaire.
Qualitative telephone interviews were scheduled the following month after patients returned their completed GCOS24dk, Version B. Interviews explored comprehension and interpretation of instructions, response options, meaning and relevance of specific items considered semantically difficult in Danish. The interviews were conducted by a languagepsychologist (co-author GO) who aimed to explore the patient's perceptions of 1) Items to which patient had answered '4' (neither disagree nor agree/not applicable to me) since this could reflect problems with item comprehensibility. 2) Items where patient had rated semantically closely related items differently across three categories: Items concerning emotions (items 4&11), understanding of referral reason (items 1, 14& 23) and knowledge about relatives' risks (items 12&18) (for wording of items please refer to Table 2 ).
3) The term 'condition' because the Danish translation ('tilstand') is not as commonly used. 4) Items considered complex in terms of grammar or negative wording (items 5, 10, 12, 17, 18) .
Participants were asked to describe in their own words how they understood the items. Notes were taken during interviews with utterances noted verbatim where possible. A thematic qualitative analysis was performed (Braun and Clarke 2006) . Data analysis additionally comprised sorting participants' responses according to whether they spontaneously mentioned having had trouble understanding the item. A list of participants' statements elaborating on item perceptions was compiled. A written report of interview findings was discussed by the expert committee before GCOS-24dk Version C was agreed upon. Beaton et al. (2000) Step Work Outcome The responsible physician recorded the type of indication for referral for each participant (categorized as oncogenetics, intellectual disability/cytogenetic aberration, eye disorder or other) and demographics for all patients screened for enrollment. All eligible patients consenting to participate were recruited into the study. A link to the electronic GCOS-24dk was e-mailed to participants 7 to 12 days after the consultation with reminder e-mails sent to non-responders weekly thereafter. All e-mails had an opt-out option.
Data Analysis
Statistical analyses were done in Stata (10.1 SE, Statcorp, Texas).
Groups were compared using two-tailed Chi-squared statistics, with demographic data analyzed using descriptive statistics. Internal consistency was assessed using Cronbach's α. To adhere to the standards set by the developers of the original English language GCOS-24, the mean of all responses on other items was used to 'impute' missing values. As with the original English language GCOS-24, GCOS-24dk scores were calculated by summing responses after inversion of scores for negatively worded items.
In order to visually examine distribution of scores and detect any floor and ceiling effects a histogram illustrating the frequencies of groups of scores was produced from data.
Results
Translation
Analysis of each forward and back translation, as well as the input of patient interviews led to iterative changes to the GCOS-24dk forms. Two major concerns were identified, namely the translation of the word Bcondition^and the translation of the Likert scale. The translation for Bcondition^used in Version A 'lidelse' was back translated to illness/disease and the translation was extensively discussed by the expert committee and with MM, co-author and developer of the original English language GCOS-24. The decision was taken to change this to the more generic and literal translation 'tilstand' in Version B. The translation of Likert scale descriptors Bstrongly agree/disagree^and Bslightly agree/disagreeŵ as also debated. The literal translation of Bstrongly^would be very definitive in Danish and probably not selected by many responders. A decision was made to use wording that literally translates to agreeing/disagreeing Bvery much^. Other minor problems in the translation of semantic, conceptual and idiomatic equivalence were identified and resolved. The test developers were consulted regarding ambiguous wording to ensure that translated items were as close as possible to the intended content. The expert committee debated whether some of item wordings might be distressing to patients, and had particular concerns regarding item 6 and advised that this be explored in patient interviews.
Test of Version B
Forty patients were approached for the test of version B, in which participants were asked to complete the GCOS-24dk and participate in a qualitative interview. Twenty-one participants returned questionnaires and 20 completed the surveys and consented to be interviewed (50% response rate). Two of the participants who agreed to be interviewed were later unable to be contacted. A total of 18 patients completed the interviews and data is included in the analysis. One patient answered only item 1 and became upset and did not want to participate further. Eighteen participants completed interviews, two were not able to be contacted.
Interview data were organized into themes representing similar meanings. Themes are presented in Table 2 . The interviews showed that in general participants understood the items in GCOS-24dk and were able to reflect appropriately about them. Only one participant expressed trouble understanding an item (item 17). As this item did not appear problematic for other participants this led to no adjustments. Furthermore several participants expressed satisfaction with the idea of helping create a tool useful for service development and improvement when enrolled in the study.
All interview participants stated that they understood the term 'tilstand' (condition). When asked to explain how they understood the term, answers fell into two themes: 1) condition understood as disease 2) condition understood as genetic flaw. The latter theme comprised both the phrase 'mutation' (mutation) and 'genetic flaw' (genetisk fejl). Participants who had not attended genetic counselling prior to completing the questionnaire associated the term 'illness' with the term 'condition'. For instance one participant said: 'well that must be my illness'. Whereas the participants who had attended genetic counselling conceptualized the term condition as Bgenetic flaw^or Bmutation^: 'well, for me it is the fact that I have this mutation'.
There was no indication in the interviews that item 6 was felt to be distressing. Regarding participants' perceptions about questions worded negatively, seven participants had stated answer 4 (Neither agree nor disagree) to item 17. When asked to recall what their thoughts when answering this item, four participants indicated that on reflection, they would like to change their response to^agree^or^strongly agree^. One participant stated in the interview 'My answer was nonsense. I do know what I can do. I slipped'. This suggests that the participant may not have understood the question when completing the questionnaire. This could also suggest that participants were concerned with how they were perceived by the interviewer and were afraid they had made mistakes.
Several participants asked what the interviewer thought was meant by a question even though the interviewer emphasized that there were no correct and incorrect perceptions.
For item 15 ' I know how to get the non-medical help I/my family need(s) (e.g. educational, financial, social support)' the probing disclosed that participants thought primarily of financial help from public sources when responding to this item. Eight chose Bneither disagree nor agree^and when asked about this they explained that they did not need financial support. The wording was adjusted for the final version so that the examples given in parenthesis in the GCOS-24dk now are patient education, encouragement, and social support.
Besides item 15, item 22 was adjusted -two alternate wording for the translation Bpowerless^had previously been discussed in the committee and the word chosen for the preliminary version was found to be too strong; one participant said 'well, I can't [do anything about it] but I don't feel powerless'.
Test of Version C
A total of 112 patients were seen at the clinic for risk assessment during recruitment for the test of version C. Eleven patients did not meet inclusion criteria (did not use e-mail (n = 5), had disabilities hindering participation (n = 4) had participated in the test of Version B (n = 2)), and seventeen patients were not invited (the physician forgot (n = 8) or felt it was inappropriate to ask (n = 4), the reason was not registered (n = 5)). Of 84 eligible patients that were invited to participate, three actively declined participation. Sixty one of the 81 invited participants completed the online survey (75.3% of eligible patient population). Fourteen did not respond to the survey and six participants used the opt-out in the electronic survey. Characteristics of the population and sample are reported in Table 3 .
Less than 0.7% of items were missing responses (10 of 1464 item response). No single responder had more than two missing values, and only one responder had two missing values. No single item had more than two missing responses (two responses each were missing for item 20 and item 21). GCOS-24dk scores ranged from 82 to 153 with a mean score of 120.8 (SD = 15.1). There was no evidence of either floor or ceiling effects. The median score was 123. The distribution of scores is illustrated in Fig. 1 . Internal consistency for GCOS24dk was high (α = 0.79). All seven response options on the Likert scale were used, supporting the translation of Bstrongly agree/disagree^chosen.
Discussion Strengths of this Study
This is the first study reporting translation and cross-cultural adaptation of a clinical genetics-specific PROM, GCOS-24, for use outside the UK. The study has created the GCOS24dk, a PROM for evaluating Danish clinical genetics services. Published guidelines for translation and cross-cultural adaptation of questionnaires were used (Beaton et al. 2000) , and led to many modifications of GCOS-24dk that proved to be of value. Noteworthy was that patient interviews revealed that Bsocial support^when literally translated was interpreted to have a different meaning in Dutch patients when compared to British patients. This is unsurprising given the differences in the social security systems between nations, but underscores the importance of using robust methods for adapting PROMs to the target culture. Indeed, GCOS-24 may need to be culturally adapted for use in Anglophone populations outside the UK. Participating patients were similar to non-participating patients. The sample composition was similar to that of the sample used for development and validation of the English language GCOS-24, but with a slightly larger proportion of oncogenetics referrals, and only one referral for the two diagnoses (congenital adrenal hyperplasia and Duchenne muscular dystrophy) that represented many of the patients participating in the original GCOS-24 development and validation study in the UK. Internal consistency, mean score and standard deviation of GCOS-24dk were similar to that reported for the English language GCOS-24 (Cronbach's α coefficient 0.79 vs. 0.87, mean score 120.8 vs. 104-121, SD 15.1 vs. 8.9-25.8) (McAllister 2016) , and in line with published quality standards for health measurement scales (Terwee et al. 2012) , however the sample size was smaller than that recommended for assessment of this property (recommended sample size: greater than or equal to 100) (Terwee et al. 2007 ).
The proportion of missing values was very low, suggesting that all items were meaningful and acceptable to participants. This was supported by the qualitative study.
Study Limitations
Although internal consistency of GCOS-24dk was assessed in this study, other psychometric properties such as structural validity, responsiveness and test-retest reliability were not examined. These properties were assessed for the English language GCOS-24, which was shown to be both stable and responsive, and it will be important to test these properties in the Danish version in a follow-up study. Although the English language GCOS-24 was originally designed to capture five domains, the exploratory factor analysis in the original validation study did not return a stable factor structure, and the authors recommended using GCOS-24 as a one dimensional scale (McAllister et al. 2011a, b) . However, it will be important to assess structural validity of GCOS-24dk in the future, in a larger sample. Furthermore, hypotheses regarding how participants' GCOS-24dk responses correlate with their responses on other related psychometric measures were not tested in this study. This was primarily because the clinical team considered that it would be too burdensome for patients to be asked to complete additional measures, but led to limited assessment of GCOS-24dk construct validity. This too, should be assessed in future research.
It is difficult to investigate how subjects understand specific sentences (James 1950; Gergen 2009; Heritage 2010) . Research interviews are one way of attempting this, but such interviews are by definition an asymmetric interaction between two people (Kvale and Brinkmann 2010) and the asymmetry is not unproblematic. Researchers may use interview techniques to minimize this asymmetry. Short non-recorded telephone interviews as used in this study provide only a crude impression of how participants perceive complex questions. Face-to-face cognitive interviews using think-alouds with concurrent with item completion (Drennan 2003; Irwin et al. 2009 ) would have been an alternative approach that would perhaps have avoided or reduced the patients' perception of being Btested^during interviews.
The purpose of the study was to translate and adapt the GCOS-24, not to further develop it. This general decision was made at the beginning of the process because it was considered of critical importance that psychometric properties of the original GCOS-24 were retained and to make comparison between countries possible. This left very limited room for changing items on the scale, even when the wording and construct of certain items were found complicated by the expert committee and this concern was backed up by patient feed-back. In these cases the items were not qualitatively changed if the committee felt that the translation was true to the original item, only adjustments and simplifications not found to alter the content of the item were made.
Practice Implications
This study was a translation/adaptation study of the English language GCOS-24 for use in Denmark. Discussions amongst the clinical team as part of the process to develop GCOS-24dk confirmed that the construct Bempowerment^captured by GCOS-24 (McAllister et al. 2011b ) is a good fit with the aims of the clinicians involved. This is important, since it has been shown that one of the major barriers to successful uptake and implementation of PROMs is clinicians' concern about whether what is measured is a genuine reflection of care (Boyce et al. 2014) . Other important obstacles to consider are the workload required to collect and analyze data and the distress that clinicians perceive that patients may experience when asked certain questions (Boyce et al. 2014) . One patient did become distressed when completing GCOS-24dk in this study. Patients attending genetics clinics are often dealing with difficult issues and may be experiencing some distress, but this may be largely related to the issue about which they are attending rather than caused by the questionnaire. GCOS-24 is easily administered on paper or electronically, and is found to be acceptable to Danish patients. PROMs can be used in service improvement, resource allocation and for measuring the impact of medical interventions (Dawson et al. 2010) . PROMs data can contribute to continuous quality improvement (e.g. by using the data to inform plan-do-study-act cycles, that otherwise might not be possible due to lack of measurable patient outcomes (Taylor et al. 2014) ).
In conclusion GCOS-24dk has been translated and reviewed by Danish patients of clinical genetics services and may be useful for future service development in Denmark. GCOS24dk is available on request. We anticipate that international colleagues will use similar approaches to adapt PROMs to support international service development enterprises.
